We are live on ! Find out more
IMUX icon

Immunic
IMUX

32 hedge funds and large institutions have $67.1M invested in Immunic in 2014 Q2 according to their latest regulatory filings, with 32 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
32
Holders Change
+32
Holders Change %
–
% of All Funds
0.92%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
32
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$21.9M
2
RIM
RS Investment Management
California
+$10M
3
BFA
BlackRock Fund Advisors
California
+$2.23M
4
Goldman Sachs
Goldman Sachs
New York
+$1.64M
5
BIT
BlackRock Institutional Trust
California
+$828K

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
AIG
26
American International Group
New York
$92.2K +$56.1K +8 New
AllianceBernstein
27
AllianceBernstein
Tennessee
$90K +$56.1K +8 New
BA
28
BlackRock Advisors
Delaware
$62K +$42.1K +6 New
Morgan Stanley
29
Morgan Stanley
New York
$36K +$21.1K +3 New
VFA
30
Virtus Fund Advisers
Connecticut
$12K +$7.02K +1 New
Wells Fargo
31
Wells Fargo
California
$10K +$7.02K +1 New
Barclays
32
Barclays
United Kingdom
$6K +$7.02K +1 New
Manulife (Manufacturers Life Insurance)
33
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$3K – – –
Citigroup
34
Citigroup
New York
$1K – – –
1
2

IMUX Hedge Fund Activity: Q2 2014 in Review

32 of the 3,479 institutional investors tracked by Wall St. Rank reported a position in Immunic (IMUX) for Q2 2014, worth a combined $67.1M.

Buyers outnumbered sellers: 32 funds opened new IMUX positions and 0 closed out — a net gain of 32 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Fidelity Investments, opening a new position worth an estimated $21.9M.

  • 32 institutional investors held Immunic (IMUX) as of Q2 2014, up from 0 in Q1 2014.
  • Funds reported $67.1M of Immunic stock for Q2 2014.
  • 32 funds opened new Immunic positions in Q2 2014 and 0 closed out, a net change of +32 holders.
  • The largest Immunic buyer in Q2 2014 was Fidelity Investments, an estimated $21.9M added.

Based on aggregated 13F filings for Q2 2014.